주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Saturday, Aprill 27, 2024, 14:40
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Samsung Chairman Talks Promotion with Pharma Giants, Bio-venture Startups in US
Jung Min-hee
2023.05.08 10:49
Entering profit margin normalization phase on solid US prescriptions and one-off cost relief
Pyeongkuk Park
2023.04.10 17:42
South Korean New Drugs Enjoying Sales Growth in the U.S.
Choi Moon-hee
2023.02.27 11:50
Samsung Biologics: Ushering in Era of Over KRW3tn in Annual Revenue
Kim Tae-hee
2023.01.31 08:43
Celltrion: Steady Growth Guaranteed in 2023
Park Pyeong-kuk
2023.01.16 18:12
Finance
Bio Industry: December US Prescription Data; Celltrion Group 4Q22 Earnings Preview
Park Pyeong-kuk
2023.01.16 18:09
Samsung Biologics: All Eyes on Plant 5 and Samsung Bioepis
Lee Dong-gun
2023.01.04 09:32
Samsung Biologics: Plant #4 to Contribute to Growth after Preparation Period in 2023
Park Pyeong-kuk
2023.01.04 09:23
Humira Biosimilar Market About to Open in the U.S.
Jung Suk-yee
2022.12.13 12:28
Chong Kun Dang Publishes Clinical Results of LucenBS in International Journal
Choi Moon-hee
2022.11.25 10:17
Finance
2023 Outlook: Bio: It’s Time for Biotech Firms to Outshine S&P500 Healthcare Players
Park Pyeong-kuk
2022.11.23 11:04
Celltrion Healthcare: Direct Sales to Begin in US
Park Pyeong-kuk
2022.11.14 13:12
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기